Prexasertib mesylate T4310L2
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Prexasertib is a potent and selective Chk1/Chk2 inhibitor. Prexasertib increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. LY2606368 causes replication catastrophe and antitumor effects through CHK1-d
CAS nr:
1234015-55-4
Purity:
98%
Molecular Weight:
461,5
SMILES:
N#CC1=NC=C(NC2=NNC(C3=C(OC)C=CC=C3OCCCN)=C2)N=C1.CS(=O)(O)=O
Formula:
C19H23N7O5S
Pathway:
Target:
